Literature DB >> 21866573

Regenerative potential of TGFβ3 + Dex and notochordal cell conditioned media on degenerated human intervertebral disc cells.

Rosalyn Delia Abbott1, Devina Purmessur, Robert Daniel Monsey, James Christopher Iatridis.   

Abstract

Injection of soluble cell signaling factors into degenerated intervertebral discs (IVDs) offers a minimally invasive treatment that could limit the processes of degeneration by stimulating native matrix repair. This study evaluated the regenerative capacity of degenerated nucleus pulposus (NP) cells obtained from patients undergoing anterior interbody fusions by measuring metabolic activity, DNA content, glycosaminoglycan (GAG) content, and cellular phenotype using qRT-PCR profiling with a custom array of 42 genes. NP cells were cultured in alginate for 7 days with 4 treatment groups: transforming growth factor beta 3 (TGFβ3) + dexamethasone (Dex), soluble factors released from notochordal cells (NCs) cultured in alginate (NCA), soluble factors released from NCs in their native tissue environment (NCT), and basal media. TGFβ3 + Dex stimulated degenerated human NP cells to proliferate and exhibit an anti-catabolic gene expression profile (with a decrease in ADAMTS5 and MMP1 compared to basal, and an increase in SOX9, decrease in ADAMTS5, MMP1, collagen I and collagen III compared to day 0), while NCA stimulated the greatest GAG per cell. We conclude that degenerated human NP cells exhibit regenerative potential, and that an optimal treatment will likely require treatments, such as TGFβ3 + Dex, which were able to increase cell metabolism and reduce catabolism, as well as treatments with factors found in NC conditioned medium, that were able to produce high amounts of GAG per cell. Additional studies to optimize NC culture conditions are required to determine if NC conditioned medium can be made with the capacity to enhance NP cell proliferation and metabolism.
Copyright © 2011 Orthopaedic Research Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21866573      PMCID: PMC3264846          DOI: 10.1002/jor.21534

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  36 in total

Review 1.  Biological repair of intervertebral disc.

Authors:  Howard S An; Eugene J-M A Thonar; Koichi Masuda
Journal:  Spine (Phila Pa 1976)       Date:  2003-08-01       Impact factor: 3.468

2.  Static compression induces zonal-specific changes in gene expression for extracellular matrix and cytoskeletal proteins in intervertebral disc cells in vitro.

Authors:  Jun Chen; Wei Yan; Lori A Setton
Journal:  Matrix Biol       Date:  2004-01       Impact factor: 11.583

3.  Influence of age-related degeneration on regenerative potential of human nucleus pulposus cells.

Authors:  Shu-Hua Yang; Chen-Chiang Lin; Ming-Hsiao Hu; Tiffany Ting-Fang Shih; Yuan-Hui Sun; Feng-Huei Lin
Journal:  J Orthop Res       Date:  2010-03       Impact factor: 3.494

4.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

5.  Age-related accumulation of the advanced glycation endproduct pentosidine in human articular cartilage aggrecan: the use of pentosidine levels as a quantitative measure of protein turnover.

Authors:  N Verzijl; J DeGroot; R A Bank; M T Bayliss; J W Bijlsma; F P Lafeber; A Maroudas; J M TeKoppele
Journal:  Matrix Biol       Date:  2001-11       Impact factor: 11.583

6.  Why the back of the child?

Authors:  X Phélip
Journal:  Eur Spine J       Date:  1999       Impact factor: 3.134

7.  Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells.

Authors:  Dong-Jun Kim; Seong-Hwan Moon; Hyang Kim; Un-Hye Kwon; Moon-Soo Park; Keong-Jin Han; Soo-Bong Hahn; Hwan-Mo Lee
Journal:  Spine (Phila Pa 1976)       Date:  2003-12-15       Impact factor: 3.468

8.  Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc.

Authors:  Christine Lyn Le Maitre; Anthony J Freemont; Judith Alison Hoyland
Journal:  J Pathol       Date:  2004-09       Impact factor: 7.996

9.  Notochordal conditioned media from tissue increases proteoglycan accumulation and promotes a healthy nucleus pulposus phenotype in human mesenchymal stem cells.

Authors:  Devina Purmessur; Rachel M Schek; Rosalyn D Abbott; Bryan A Ballif; Karolyn E Godburn; James C Iatridis
Journal:  Arthritis Res Ther       Date:  2011-05-31       Impact factor: 5.156

10.  BMP-2 and TGF-beta stimulate expression of beta1,3-glucuronosyl transferase 1 (GlcAT-1) in nucleus pulposus cells through AP1, TonEBP, and Sp1: role of MAPKs.

Authors:  Akihiko Hiyama; Shilpa S Gogate; Sachin Gajghate; Joji Mochida; Irving M Shapiro; Makarand V Risbud
Journal:  J Bone Miner Res       Date:  2010-05       Impact factor: 6.741

View more
  35 in total

1.  Reduced tissue osmolarity increases TRPV4 expression and pro-inflammatory cytokines in intervertebral disc cells.

Authors:  B A Walter; D Purmessur; A Moon; J Occhiogrosso; D M Laudier; A C Hecht; J C Iatridis
Journal:  Eur Cell Mater       Date:  2016-07-19       Impact factor: 3.942

2.  Intact glycosaminoglycans from intervertebral disc-derived notochordal cell-conditioned media inhibit neurite growth while maintaining neuronal cell viability.

Authors:  Devina Purmessur; Marisa C Cornejo; Samuel K Cho; Peter J Roughley; Robert J Linhardt; Andrew C Hecht; James C Iatridis
Journal:  Spine J       Date:  2015-02-07       Impact factor: 4.166

3.  Detrimental effects of discectomy on intervertebral disc biology can be decelerated by growth factor treatment during surgery: a large animal organ culture model.

Authors:  Svenja Illien-Jünger; Young Lu; Devina Purmessur; Jillian E Mayer; Benjamin A Walter; Peter J Roughley; Sheeraz A Qureshi; Andrew C Hecht; James C Iatridis
Journal:  Spine J       Date:  2014-04-24       Impact factor: 4.166

4.  Can notochordal cells promote bone marrow stromal cell potential for nucleus pulposus enrichment? A simplified in vitro system.

Authors:  Esther Potier; Keita Ito
Journal:  Tissue Eng Part A       Date:  2014-12       Impact factor: 3.845

5.  Inflammatory Kinetics and Efficacy of Anti-inflammatory Treatments on Human Nucleus Pulposus Cells.

Authors:  Benjamin A Walter; Devina Purmessur; Morakot Likhitpanichkul; Alan Weinberg; Samuel K Cho; Sheeraz A Qureshi; Andrew C Hecht; James C Iatridis
Journal:  Spine (Phila Pa 1976)       Date:  2015-07-01       Impact factor: 3.468

6.  Conditioned medium derived from notochordal cell-rich nucleus pulposus tissue stimulates matrix production by canine nucleus pulposus cells and bone marrow-derived stromal cells.

Authors:  Stefan A H de Vries; Esther Potier; Marina van Doeselaar; Björn P Meij; Marianna A Tryfonidou; Keita Ito
Journal:  Tissue Eng Part A       Date:  2014-12-17       Impact factor: 3.845

7.  Degenerative grade affects the responses of human nucleus pulposus cells to link-N, CTGF, and TGFβ3.

Authors:  Rosalyn D Abbott; Devina Purmessur; Robert D Monsey; David R Brigstock; Damien M Laudier; James C Iatridis
Journal:  J Spinal Disord Tech       Date:  2013-05

8.  Soluble factors from the notochordal-rich intervertebral disc inhibit endothelial cell invasion and vessel formation in the presence and absence of pro-inflammatory cytokines.

Authors:  M C Cornejo; S K Cho; C Giannarelli; J C Iatridis; D Purmessur
Journal:  Osteoarthritis Cartilage       Date:  2014-12-19       Impact factor: 6.576

9.  Development of a bovine decellularized extracellular matrix-biomaterial for nucleus pulposus regeneration.

Authors:  Svenja Illien-Jünger; Dillon D Sedaghatpour; Damien M Laudier; Andrew C Hecht; Sheeraz A Qureshi; James C Iatridis
Journal:  J Orthop Res       Date:  2015-12-01       Impact factor: 3.494

10.  Intracellular signaling mechanisms associated with CD47 modified surfaces.

Authors:  Matthew J Finley; Katherine A Clark; Ivan S Alferiev; Robert J Levy; Stanley J Stachelek
Journal:  Biomaterials       Date:  2013-08-13       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.